ADXN Addex Therapeutics
- 8.0900
- -0.1100-1.34%
Addex Therapeutics News
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | F-6 POS: Post-effective amendment to a F-6EF registration
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
No Data